Skip to main content

Table 4 Circuit and target lesion (CAS) patency rates at 3,6, and 12 months

From: Treatment of cephalic arch stenosis in dysfunctional arteriovenous fistulas with paclitaxel-coated versus conventional balloon angioplasty

  All POBA PCB P-value
3-month outcomes
 N 88 63 25  
 Circuit primary patency, n (%) 63 (71.6) 46 (76.2) 15 (60) 0.209
 Circuit primary assisted patency, n (%) 82 (93.2) 59 (93.7) 23 (92) 1.000
 Target lesion patency, n (%) 67 (76.1) 50 (79.4) 17 (68) 0.395
6-month outcomes
 N 87 62 25  
 Circuit primary patency, n (%) 36 (41.4) 27 (43.5) 9 (36) 0.685
 Circuit primary assisted patency, n (%) 74 (85.1) 54 (87.1) 20 (80) 0.508
 Target lesion patency, n (%) 45 (51.7) 32 (51.6) 13 (52) 1.000
12-month outcomes
 N 81 59 22  
 Circuit primary patency, n (%) 15 (18.5) 13 (22) 2 (9.1) 0.219
 Circuit primary assisted patency, n (%) 63 (77.8) 45 (76.3) 18 (81.8) 0.767
 Target lesion patency, n (%) 25 (30.9) 20 (33.9) 5 (22.7) 0.485
  1. POBA Plain Old Balloon Angioplasty, PCB Paclitaxel Coated Balloon